San Diego's Vital Therapies, Inc. (VTI) Lowers The Bar With 2nd IPO Try
Vital Therapies lowers the bar in its 2nd try at an initial public offering, aiming to raise up to $68 million this time around.
Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.
Help employers find you! Check out all the jobs and post your resume.